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ABSTRACT 
This paper presents a hybrid simulation model for the management of an eye condition called age-related 
macular degeneration, which particularly affects the elderly. The model represents not only the detailed 
clinical progression of disease in an individual, but also the organization of the hospital clinic in which 
patients with this condition are treated and the wider environment in which these patients live (and their 
social care needs, if any, are met). The model permits a ‘whole system’ societal view which captures the 
interactions between the health and social care systems.  
1  INTRODUCTION 
This paper models the treatment and progression of age-related macular degeneration (AMD)—a com-
mon form of visual impairment in the elderly—in the UK county of Hampshire, working with the South-
ampton General Hospital Eye Unit. Although at its core a classic OR problem in improving the efficiency 
of the clinic, the model attempts a whole system view which incorporates the relationships between health 
and social care for sufferers, and related cross-service planning and budgeting issues for the stakeholders. 
This suggests the need for a hybrid model using discrete-event simulation (DES), agent-based modeling 
(ABM) and system dynamics (SD), chosen so as to use the ‘best tools for the job’ rather than rigidly 
sticking to one paradigm. Both this methodological fusion and the whole system view are overarching 
themes of the Care Life Cycle (CLC) project which the work is a part of (Care Life Cycle 2012); these 
themes are echoed in the other CLC-related papers at this conference (Brailsford, Evandrou et al. 2012; 
Noble, Silverman et al. 2012). 
1.1  Clinical & Social Context 
Visual impairment is a common form of disability amongst the elderly in the UK, with estimates of the 
numbers over 65 suffering from some form of impairment ranging from 1.6m to 2.2m (Charles 2007). 
The most common cause of visual impairment in this age group is AMD, a progressive degenerative dis-
ease that causes the loss of central vision (The Eye Diseases Prevalence Research Group 2004). Due to 
the increasing older adult population over the age of 65 in the UK it is predicted that the numbers with 
AMD will increase, from just over 600,000 in 2010 to over 750,000 in 2020 (Minassian, Reidy et al. 
2011). The estimated cost of this disability, in detection, treatment and the provision of care is £1.6 billion 
per year (Minassian and Reidy 2009). Viana, Rossiter, Channon, Brailsford, and Lotery 
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There are many forms of AMD, although they are broadly grouped as being either ‘wet’ and ‘dry’, 
with ‘wet’ AMD consisting of between 65-70% of the total disability burden (Minassian, Reidy et al. 
2011). The ‘dry’ form of AMD is irreversible and is characterized by a slow transition to impairment, 
while the ‘wet’ form results in more rapid visual deterioration. However it can usually be treated using in-
jections of ranibizumab which slows the impairment or even causes vision to improve (Lotery 2008). 
These injections need to be given at regular monthly intervals in order to show benefit to the patient. This 
is a new treatment and many hospital eye units do not have the organizational structure nor the capacity to 
manage the regular need for injections or consulting. Appointment booking systems are not efficient at 
managing this regular need for care. 
The implications of visual impairment in general, and AMD in particular, are wide-ranging. Those 
with AMD are seen to be more likely to be depressed (Brody, Gamst et al. 2001), have a lower quality of 
life (Slakter and Stur 2005; Hassell, Lamoureux et al. 2006) and less functional independence (Williams, 
Brody et al. 1998). It is estimated that mild AMD causes a similar reduction in the quality of life as mod-
erate cardiac angina (Brown, Brown et al. 2005). The reduced vision interferes with the ability to self-care 
(Stevenson, Hart et al. 2004), leading to increasing reliance on both formal (i.e., provided through an es-
tablished channel) and informal (i.e., given by family or friends) social care. Without this care the indi-
vidual may not be able to function on their own and require a higher level of health care for non-visual re-
lated health issues. 
The Eye Unit at Southampton General Hospital is the sole treatment center for AMD in the UK coun-
ty of Hampshire. It is currently providing injections for those with wet AMD but it is not felt that this is 
being conducted in the most efficient manner. Furthermore there is concern about the ability of the Unit to 
cope with the growing ageing population, which could potentially lead to a number of patients failing to 
receive the care that they require, increasing the social care burden. 
This paper focuses on the development and treatment of ‘wet’ AMD in the area served by the South-
ampton Eye Unit. Sufferers of the condition have related care needs, often complicated by other condi-
tions due to the age-related nature of AMD. These needs may or may not be met through receiving social 
care, either formally (provided by the state or privately) or informally (provided by family and friends). 
Formal social care is determined after an assessment of need while informal care depends on the network 
of friends and family surrounding the individual. The social care obtained also links with the ease of trav-
elling to Southampton General Hospital for treatment – those with little support will find this more diffi-
cult and may miss appointments leading to further deterioration of vision, enhancing the need for social 
care. The Eye Unit needs to be organized to allow treatment of the maximum numbers of patients without 
reducing the patient experience.  
The study has been carried out in collaboration with the Southampton Eye Unit in order to explore al-
ternative configurations of the clinic in the safety of a computer environment, including potential options 
such as mobile eye unit which perform time-consuming eye photography to alleviate pressure on shared 
facilities at the clinic. Through exploring different potential configurations of care given at the Eye Unit, 
changes in the efficiency of the Unit can be estimated as well as the corresponding improvements in 
health and reductions in the need for social care. Ultimately, the work also aims to highlight how expendi-
ture in one area (health or social care) may cause non-obvious cost implications in the other (e.g., im-
proved social care transport services saving considerable amounts in the clinic due to less missed ap-
pointments, and with knock-on savings in social care due to less avoidable AMD sight loss). 
2  METHODOLOGY 
Figure 1 illustrates the conceptual architecture of the model, which is not yet fully realized in the current 
implementation (section 3) but guides the work. DES and SD components sit inside an overarching agent-
based model. Individuals (agents) in the population may develop AMD, alongside other conditions, and 
have varying levels of care need. Some may provide informal care to others.  Embedded SD models in 
each individual model progressive sight loss from AMD and other conditions. Individuals with eye condi-
tions (not just AMD) will interact with the healthcare system via the ophthalmology department and, po-Viana, Rossiter, Channon, Brailsford, and Lotery 
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tentially, mobile units. The clinic is modeled as a DES with explicit appointment scheduling processes. 
Doctors interact with this clinic, and may respond to scheduling pressures (e.g., by adjusting the slots in 
their timetables for different conditions). 
Interactions occur in a spatial environment, which can be used to model aspects such as ability to 
travel to the clinic, the location of those providing care to AMD sufferers (which influences their ability 
to provide care), and the positioning of mobile eye units. 
 
 
Figure 1: The overall conceptual architecture for the AMD model. 
The  hybridization  in  the  model  here  can  be  seen  as  an  elaborate  combination  of  “process–
environment” type combinations (Chahal and Eldabi 2008), if their focus on DES and SD is relaxed to in-
clude ABM. Sub-models sit inside other models, with the inner model representing a process which inter-
acts with the wider system environment of the outer model. A similar approach was used in the two illus-
trative examples of Brailsford, Desai et al. (2010). In Swinerd and McNaught’s terminology for ABM and 
SD hybrids (2012), the model uses flavors of their “integrated” hybrid design alternative (cf. “interfaced” 
or “sequential”), with a similar need to relax the specific focus.  
he modeling here is primarily motivated by using the best combination of tools, rather than any claim 
of novel hybridization. By ‘best’, we mean using the modeling paradigm which most cleanly implements 
the conceptual design we had in mind for each sub-system. This is discussed per sub-system in section   3. 
By combining the different methodologies which are best suited for their particular tasks, the stakeholders 
have gained greater buy-in and understanding, where the stakeholders include both the problem owners 
(health care and social care professionals) and those members of the project team who are unfamiliar with 
the techniques. In technical terms, the modeling framework used (AnyLogic) natively provides constructs 
with which to link the paradigms; some simple additional ‘plumbing’ code was still needed to allow 
agents to pass through the DES wrapped in a DES entity object. 
2.1  Stakeholder Interaction 
The model was developed with input from staff at the Eye Unit, but not in a fully stakeholder-driven pro-
cess. The DES models the clinic at a fine-grained time resolution, but the long-term effects of treatments 
on sight loss are also of interest, particularly with feedback effects due to changes in social care and its 
influence on missed injections. These long timescales mean that assumptions have to be made about what Viana, Rossiter, Channon, Brailsford, and Lotery 
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is subject to change and what can be regarded as static. The emphasis therefore has to be on presenting 
challenging ‘what-if’ scenarios, and not ‘best guess’ projections or predictions.  
2.2  Scenarios  
There are a wide range of potential ‘what-if’ scenarios that could be explored within this conceptual 
framework. In general, the clinic DES model (section 3.2) and sight loss SD models ( section 3.3) can be 
used to explore health care scenarios, and the agent-based elements (section 3.4) to explore social care 
scenarios. The social care consequences can be evaluated in terms of health care scenarios, and vice ver-
sa. Examples of potential scenarios which could be evaluated are shown in Table 1.Table 1: Potential sce-
narios for evaluation. 
Health Care  Social Care 
Ophthalmology department efficiency  
Patient  pathways,  opening  times,  ap-
pointment times, availability of resources 
both  staff  and  medical  facilities  for  ex-
ample.  
Social care need 
Changing development rates for varying 
levels  of  care  need  in  relation  to  age, 
and the specific impact of AMD on the-
se rates. 
Sight loss and AMD Stages 
Differing  models  of  sight  deterioration 
(both natural and AMD), and the effects 
of  differing  treatments  (including  indi-
vidual heterogeneity in response). 
Social care provision 
Changes in the patterns of care provided 
to those in need (both level and type). 
 
 For the current paper the aim is to demonstrate the interconnectedness between the health and social care 
systems, highlighting how changes in one sphere can result in changes to the other. Four different scenar-
ios are therefore investigated, representing: the current situation, changes to the healthcare supply, chang-
es to the social care supply, and a combination of the two. These will be fully explained in section 4.2.  
3  DETAILS OF THE MODEL 
The current model represents a stepping-stone towards the full aspirations highlighted in section 2. 
Most areas have been parameterized with accurate data from various sources, the main ones being: the 
English Longitudinal Study of Ageing (ELSA 2012),  the Age-Related Eye Disease Study Group (Age-
Related Eye Disease Study Research 2000; Age-Related Eye Disease Study Research 2005), the Royal 
National Institute of Blind People (Access Economics PTY Limited 2009), and information directly ob-
tained  from  the  Eye  Unit  regarding  operation  and  performance.  Fuller  details  can  be  found  at 
http://www.soton.ac.uk/clc/publications/supplementary, together with the parameters used from these data 
sources in different parts of the model.  
The  model  is  implemented  in AnyLogic  (www.xjtek.com/AnyLogic),  a commercial package  that 
supports the integration of DES, SD and agent-based models, with features for each comparable to para-
digm-specific products. 
 
3.1  Overall Structure 
Individuals develop AMD, and will then interact with the DES that represents the eye clinic via appoint-
ments (see Figure 2). 
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Figure 2: The main per-individual dynamics of interaction with the eye clinic. Numbers indicate the se-
quence of operations. 
On an initial AMD diagnosis, the individual (agent) is scheduled for an initial appointment and stores this 
information, effectively setting up an event for the appointment time. The patient then attends the ap-
pointment, at which point it interacts with the eye clinic DES. After the appointment is finished the agent 
leaves the DES model and the next appointment, which may be either a follow-up or an injection ap-
pointment, is scheduled This scheduling currently uses some simplifying assumptions about the number 
and duration of available slots, but still captures the essence of the real-life mechanism. This dynamic cy-
cle of appointments continues until other events, such as death, intervene. The treatment that the individu-
al may or may not receive impacts the progression of his/her sight loss in the agent-embedded SD models. 
Individuals can miss appointments for a variety of reasons (such as transport difficulties, illness or 
simply through forgetfulness) and can fail to complete appointments (generally due to excessive queues in 
the clinic, or due to insufficiently flexible transport arrangements). In both cases, an injection is missed 
which will cause avoidable sight deterioration. These are the main mechanisms by which social care is-
sues can influence the clinic’s operation. Missed appointments are modeled as probabilities based on the 
individual’s care need and the type of care received (where need and provision levels map to multipliers 
applied to a basic fixed probability of missing the appointment). Incomplete appointments are modeled as 
probabilities based on time spent queuing. These parameters are currently based on expert opinion, but 
there is potential to use empirical data to improve them. 
3.2  Eye Clinic DES Model 
The choice of DES to model the Eye Unit is natural to simulate the detailed processes and layout of the 
system. Clearly this is unique to the context, but in overall structure and concept it is a standard DES out-
patient clinic model in a long tradition of such queuing network type models.  Jun et al. (1999) present a 
survey of 117 such clinic models, although obviously not all for eye conditions, and this is a classical ap-
plication area for DES in health.   
DES has also been applied, unusually, for modeling the clinical progression of eye disease by Davies 
et al. (2000; 2002), in order to evaluate the effectiveness of different screening policies for diabetic reti-
nopathy. The approach most typically used to model clinical progression in economic evaluations of in-
terventions is either Markov modeling or decision tree analysis (Cooper, Brailsford and Davies 2007).  In 
the specific case of AMD, there are a small number of published models which use models to study the 
cost-effectiveness or cost-utility of different drugs, for example Fletcher et al. (2008), but none that use 
DES. 
Staff from the clinic have been involved in the conceptualization of the model, helping to define the 
patient pathways and physical layout of the clinic. AnyLogic allows the entities to be modeled physically Viana, Rossiter, Channon, Brailsford, and Lotery 
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moving through the clinic space as they go through the steps of the pathway. The results shown here use 
modeler estimates for the parameters. The clinic is hoping to make internal tracking data available soon, 
which can be used to derive more empirically-driven values. A patient questionnaire will also be incorpo-
rated to aid  the parameterization of the patients’ behavior outside the clinic, such as their mode of 
transport to the clinic, who accompanied them to the clinic and care relationships. 
Full  details  of  the  DES  model  structure  and  data  are  available  on  our  project  Web  site  at 
http://www.soton.ac.uk/clc/publications/supplementary.  
3.3  Sight Loss and AMD Progression (State-Transition and Embedded SD Models) 
The process of sight loss, both natural and AMD-related, lends itself to a rate-based mathematical repre-
sentation which SD models are ideal for. (In our case, ‘natural’ could conceptually include other non-
AMD eye conditions.) Sight level is modeled very simply as a stock which is decreased via natural and 
AMD loss rates. The progression of AMD itself is modeled by a simple set of stochastic stage transitions 
(using AnyLogic statecharts), where the stages cause changes in the AMD-related sight-loss rate. AMD 
does not affect each eye identically. As a result, sight loss progresses differently in each eye and hence 
each agent actually has a pair of SD models (one for each eye),  each parameterized separately. Figure 3 
shows a schematic of the SD model used for the left eye;  the model for the right eye is the same. Obtain-
ing an injection will slow the AMD-related degeneration of sight (Lotery 2008).  
 
 
  Figure 3: Schematic of the SD model for an eye. 
There is individual heterogeneity, both for each eye and between individuals, including in their reac-
tion to injections and the ‘virulence’ of their AMD. Future work will align this sub-model more explicitly 
with specific clinical details of sight loss and AMD progression (e.g. Klein, Klein et al. 2002; Owen, 
Jarrar et al. 2012). 
3.4  Individual Care, Mortality and AMD Development 
Conceptually (as described in Figure 1), the model has a full population of individuals who will develop 
AMD and form care relationships. Implementing this in an empirically accurate way via explicit, endoge-
nous agent behavior is a major challenge, and is an area of research in its own right. (It is typically done 
via regression-model-driven microsimulation, but see Noble et al. (2012) for other approaches being con-
sidered on the CLC project.) 
To simplify matters, the current model abstracts away this detail. Only AMD-suffering individuals are 
explicitly included in the population, and are created synthetically based on current numbers of new pa-
tients, with incidence data used to set initial attributes such as age and gender. (These therefore represent 
patients already referred.) Dynamically changing care needs are modeled using statecharts, with the type 
of care provided stochastically derived from care need level. Transitions are based on cross-tabulated 
population-level statistics. An individual’s AMD progression is linked to care need by having sight-level Viana, Rossiter, Channon, Brailsford, and Lotery 
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categories imposing a minimum level of care need (with some stochastic variation). Mortality is based on 
population-level age-dependent life tables, with per-year checks, and is a significant factor since at least 
30% of AMD diagnoses are for 90+ year-olds.  
The accuracy of these parameters is currently limited by the fact that  population-level data should 
ideally be adjusted so that it reflects distributions for AMD-sufferers in particular. This is still work in 
progress. 
 
3.5  Current Output Measures 
The current main output measures available from the model are as below:  
 
Medical (DES)  Health and Social (ABM, SD) 
Length of stay in the clinic.  AMD-suffering population size and mortality. 
Numbers of missed injections (due to missed ap-
pointments or leaving appointments early). 
AMD stage distribution in the population. 
Numbers of patients treated and quality criteria for 
timeliness of appointments. 
Care provision types distribution in the popula-
tion. 
Utilization  of  Ophthalmology  resources  (rooms, 
staff, waiting areas, etc.). 
Sight level distribution in the population. 
  Care need level distribution in the population. 
 
4  EXPERIMENTATION 
As discussed in section 2.2, four ‘what-if’ scenarios were run in the current model to explore the inter-
connectedness of the health and social care systems. For the purposes of this paper, the number of missed 
injections was chosen as the main output measure for discussion (see section 4.3), since this is a rough 
proxy both for the efficiency of the healthcare system and the effectiveness of care provision in the com-
munity. 
This exploration was originally intended to include extensive analysis of and the sensitivity of several 
outcome measures to key parameters, as well as using an initial and ongoing AMD-suffering population 
that matched the clinic’s current levels: around 1600 ‘AMD eyes’, which thus maps to 800-1600 individ-
uals and, at least at some stages, 20 new patients a week.  Run lengths of  30 years were planned so that 
the longer-term dynamics of sight loss and ageing could be explored. Unfortunately, even with considera-
ble performance tuning, models with only 50 initial individuals and 2 new patients a week (on average) 
would take over 28 hours to run 15 simulated years on a relatively high specification system (AMD Phe-
nom II at 3.1GHz). 
The current results are therefore scaled back to representative runs for 1 simulated year for each sce-
nario, with 50 initial individuals and 2 new patients a week. The original analysis can hopefully be per-
formed in future, via further performance tuning  and/or increased computing resources and timescales. 
4.1  Scenarios tested  
These are: 
1.  Base – The Eye Unit appointment system and organization remains as it currently is for the entire 
simulation duration. Data for the other health and social aspects of the model remain constant, 
drawn from the literature, data analysis of surveys, expert opinion and educated guesses. This is 
the scenario against which all others will be compared. 
 Viana, Rossiter, Channon, Brailsford, and Lotery 
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2.  Healthcare – In this scenario an additional Optical Coherence Tomography (OCT) machine is in-
stalled in the Eye Unit. After initial analysis and discussions with clinical members of the Unit, it 
was observed that this is the key area where current bottlenecks are observed in the system. 
 
3.  Social care – As not all individuals who need social care currently receive it, this scenario simu-
lates some nominal care provision stimulus. Individuals have a 50% chance of receiving one ‘lev-
el’ better care than they would have previously, where the care provision types None, Informal, 
Formal and Both are viewed as an increasing sequence of levels (and with increasingly less nega-
tive effects on the likelihood of missing clinic appointments). 
 
4.  Healthcare and Social Care – this scenario combines scenarios 2 and 3 above. 
 
4.2  Results  
The results from single representative runs are shown in Figure 1. They suggest that improving the Eye 
Unit’s capability by increasing the number of OCT machines results in more patients successfully com-
pleting their appointments, as fewer patients leave the department who have waited an excessive amount 
of time. Increasing the amount of social care also has a positive effect when compared with the base, with 
more patients being able to attend their appointments.  What is somewhat counterintuitive at this stage is 
that the combined scenario leads to less reduction in numbers of missed appointments over time than the 
individual scenarios on their own. A possible explanation for this is that the increased appointment at-
tendance from the social care scenario places more pressure on the clinic than the extra OCT (healthcare 
scenario) can alleviate. Thus, reduced missed appointments are outweighed by increased incomplete ap-
pointments. 
  
 
Figure 4: Results from initial experiments for the four scenarios. 
5  FUTURE WORK 
Future areas of work have been hinted at in the conceptual design (figure 1) and in the detail of the model 
and current results. These fall into the following broad categories: 
•  performance analysis of the model and the underlying AnyLogic platform; 
•  better quality data, reflecting the distributional specifics of the AMD-suffering population; Viana, Rossiter, Channon, Brailsford, and Lotery 
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•  more accurate demographic processes (e.g., factoring in demographic change to the number 
of new AMD cases); 
•  a  more  empirically-validated  sight  loss  sub-model, with  related quality-adjusted  life  year 
(QALY) style metrics for avoidable sight-years lost due to system inefficiencies; 
•  more accurate reflection of the appointment scheduling process used; 
•  adding more nuanced detail of links between health and social care (e.g., inflexible hospital-
provided transport causing patients to have to leave appointments early, and better alignment 
of AMD progression with care need); 
•  increased spatiality, especially as regards scenarios for mobile eye-photography units; 
•  more ‘ABM-like’ explicit agent behavior, both for individuals in the population and doctors 
at the clinic, which can endogenously generate patterns of care provision and the like; 
•  estimates of the resultant impacts on costs in both the health and social care sectors (which 
will involve additional stakeholders). 
 
6  CONCLUSIONS 
This work has created a useful whole system modeling framework for health and social care. The aim of 
the CLC project is to take this whole system view, looking at each of the quadrants in Figure 5. There are 
many links between each of these areas, and this model has highlighted some of these for one disease 
(AMD). Focusing on a single disease has helped reduce the inevitable complexity, but the generality of 
some of the concepts and design suggests extensions beyond AMD. The project aims to use the right tools 
for the job (particularly ideas from complexity science) to demonstrate and understand the interactions 
and feedback between health and social care. The model here uses different components, constructed for 
specific purposes, which are then combined into a complete model. As a result it is easier to discuss it 
with stakeholders as they can focus on the area that is of most interest to them. 
 
  Demand  Supply 
Health Care  A  B 
Social Care  C  D 
Figure 5: The quadrants of interest to the CLC project, reflecting the demand and supply of health and so-
cial care. 
More generally, stakeholders can get ‘traditional’ OR advice on operational improvements whilst em-
phasizing the broader societal context, especially the sometimes-subtle effects of healthcare decisions on 
social care (and vice versa). This will be particularly useful going forwards, since the longer-term aim is 
to involve budget-holding stakeholders from health and social care, allowing them to see the broader im-
plications and mutuality of their decisions. In England, the health and social care budgets are currently to-
tally separate. Healthcare is funded by the taxpayer: it is provided by the National Health Service (NHS) 
and is free to the patient at the point of delivery. On the other hand, social care is provided by several dif-
ferent sources: informal care provided unpaid by family members or friends, and formal care provided ei-
ther by the local county authority where the person lives, the private sector, or the voluntary sector.  This 
model demonstrates the politics involved in a situation where relatively short-term expenditure by the 
NHS (e.g., providing an extra OCT machine in the clinic) can lead to longer-term cost savings for the lo-
cal authority, since fewer people will go blind and require expensive residential care. Preventing avoida-
ble sight loss in the elderly not only makes sense from a humanitarian perspective, it also makes sense 
from an economic perspective. However, without a whole system model which takes a societal perspec-Viana, Rossiter, Channon, Brailsford, and Lotery 
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tive, it is difficult to see why the NHS should bear the entire cost. The model provides a mechanism to 
explore such trade-offs.    
The  integration  of  DES,  ABM  and  SD  in  a  health  care  context  is  rare.  This  study  adds  to  the 
knowledge base regarding the benefits of doing this, alongside the issues regarding truly integrated mod-
els – the ‘holy grail’. The main conceptual difficulties lie in designing sub-components and their interac-
tions so that they represent the real-world complexity without overwhelming the model with impenetrable 
detail. This process is both enriched and made more challenging by the combination of disciplines in-
volved. The work required a marriage of an OR stakeholder-driven approach, with the ‘empirical eye’ of 
social statisticians and the micro-level theories of complexity science. Social statistics helped make in-
formed decisions on where mechanisms could be abstracted from  relationships in empirical data, rather 
than having the causal mechanisms modeled explicitly. However, the latter is a strong current in complex-
ity science, and promises to help in better modeling individuals’ adaptation to changing social and tech-
nological contexts, which the scenarios explored here represent. Future work may therefore move further 
towards this style of theory-driven modeling, à la Noble et al. (2012). 
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